These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Anticipating phenotypic differences from genetic mutations. You YN Dis Colon Rectum; 2015 Jan; 58(1):143-4. PubMed ID: 25489706 [No Abstract] [Full Text] [Related]
8. Tumor Screening and DNA Testing in the Diagnosis of Lynch Syndrome. Usha L; Dewdney SB; Buckingham LE JAMA; 2016 Jul; 316(1):93-4. PubMed ID: 27380347 [No Abstract] [Full Text] [Related]
10. Lynch syndrome (hereditary nonpolyposis colorectal cancer) diagnostics. Lagerstedt Robinson K; Liu T; Vandrovcova J; Halvarsson B; Clendenning M; Frebourg T; Papadopoulos N; Kinzler KW; Vogelstein B; Peltomäki P; Kolodner RD; Nilbert M; Lindblom A J Natl Cancer Inst; 2007 Feb; 99(4):291-9. PubMed ID: 17312306 [TBL] [Abstract][Full Text] [Related]
11. Counterpoint: implementing population genetic screening for Lynch Syndrome among newly diagnosed colorectal cancer patients--will the ends justify the means? Hall MJ J Natl Compr Canc Netw; 2010 May; 8(5):606-11. PubMed ID: 20495087 [TBL] [Abstract][Full Text] [Related]
12. Feasibility of screening for Lynch syndrome among patients with colorectal cancer. Hampel H; Frankel WL; Martin E; Arnold M; Khanduja K; Kuebler P; Clendenning M; Sotamaa K; Prior T; Westman JA; Panescu J; Fix D; Lockman J; LaJeunesse J; Comeras I; de la Chapelle A J Clin Oncol; 2008 Dec; 26(35):5783-8. PubMed ID: 18809606 [TBL] [Abstract][Full Text] [Related]
13. The biochemical basis of microsatellite instability and abnormal immunohistochemistry and clinical behavior in Lynch syndrome: from bench to bedside. Boland CR; Koi M; Chang DK; Carethers JM Fam Cancer; 2008; 7(1):41-52. PubMed ID: 17636426 [TBL] [Abstract][Full Text] [Related]
14. Preoperative diagnosis of Lynch syndrome with DNA mismatch repair immunohistochemistry on a diagnostic biopsy. Warrier SK; Trainer AH; Lynch AC; Mitchell C; Hiscock R; Sawyer S; Boussioutas A; Heriot AG Dis Colon Rectum; 2011 Dec; 54(12):1480-7. PubMed ID: 22067175 [TBL] [Abstract][Full Text] [Related]
15. Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients. Hampel H; Frankel W; Panescu J; Lockman J; Sotamaa K; Fix D; Comeras I; La Jeunesse J; Nakagawa H; Westman JA; Prior TW; Clendenning M; Penzone P; Lombardi J; Dunn P; Cohn DE; Copeland L; Eaton L; Fowler J; Lewandowski G; Vaccarello L; Bell J; Reid G; de la Chapelle A Cancer Res; 2006 Aug; 66(15):7810-7. PubMed ID: 16885385 [TBL] [Abstract][Full Text] [Related]
16. [Recent advances and future development on Lynch syndrome-associated endometrial cancer]. Ning Y; Wang Y; Wang YY; Zheng WX Zhonghua Bing Li Xue Za Zhi; 2013 Aug; 42(8):505-8. PubMed ID: 24246913 [No Abstract] [Full Text] [Related]
17. Point: justification for Lynch syndrome screening among all patients with newly diagnosed colorectal cancer. Hampel H J Natl Compr Canc Netw; 2010 May; 8(5):597-601. PubMed ID: 20495086 [TBL] [Abstract][Full Text] [Related]
18. Exome sequencing in diagnostic evaluation of colorectal cancer predisposition in young patients. Tanskanen T; Gylfe AE; Katainen R; Taipale M; Renkonen-Sinisalo L; Mecklin JP; Järvinen H; Tuupanen S; Kilpivaara O; Vahteristo P; Aaltonen LA Scand J Gastroenterol; 2013 Jun; 48(6):672-8. PubMed ID: 23544471 [TBL] [Abstract][Full Text] [Related]
19. In Lynch syndrome adenomas, loss of mismatch repair proteins is related to an enhanced lymphocytic response. Meijer TW; Hoogerbrugge N; Nagengast FM; Ligtenberg MJ; van Krieken JH Histopathology; 2009 Oct; 55(4):414-22. PubMed ID: 19817892 [TBL] [Abstract][Full Text] [Related]
20. Epitope-positive truncating MLH1 mutation and loss of PMS2: implications for IHC-directed genetic testing for Lynch syndrome. Zighelboim I; Powell MA; Babb SA; Whelan AJ; Schmidt AP; Clendenning M; Senter L; Thibodeau SN; de la Chapelle A; Goodfellow PJ Fam Cancer; 2009; 8(4):501-4. PubMed ID: 19672700 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]